Medical Disclaimer: These calculators may contain errors and are for reference only — always reconfirm results with a qualified physician before clinical use.
kg

How the dose is calculated

Ceftriaxone is dosed in mg/kg/day. Standard dosing is once daily, taking advantage of its long half-life; severe infections including meningitis use a higher total daily dose divided every 12 hours. This is an injectable (IV/IM) antibiotic — no suspension volume conversion applies.

Typical dosing by indication

IndicationDoseFrequencyMax
Standard50 mg/kg/dayonce daily2000 mg/day
Severe/meningitis-range100 mg/kg/dayevery 12h (2×/day)4000 mg/day

Ceftriaxone is supplied as a powder for reconstitution (IV/IM) — there is no oral suspension, so this calculator reports the mg dose only; follow your local pharmacy's reconstitution and infusion protocol for the actual volume to administer.

Clinical use

Frequently asked questions

Why is ceftriaxone often given only once a day?

Its long half-life keeps drug levels therapeutic for a full 24 hours after a single dose for most indications, which is why once-daily dosing is standard outside of meningitis-range regimens.

Can ceftriaxone be given with calcium-containing IV fluids?

Not in neonates — concurrent IV ceftriaxone and calcium-containing solutions have been linked to fatal precipitates in the lungs and kidneys in this age group, so local neonatal protocols specifically avoid this combination.

Why does the meningitis dose differ from the standard dose?

Meningitis and other severe CNS infections need higher and more sustained drug concentrations to adequately penetrate the blood-brain barrier, so a higher total daily dose split into two doses is used instead of the standard once-daily regimen.

Is ceftriaxone available as a tablet or syrup?

No — ceftriaxone is only available as an injectable (IV or IM) formulation; there is no oral tablet or suspension form.

References

  1. American Academy of Pediatrics Red Book — Ceftriaxone.
  2. Tunkel AR, et al. Practice Guidelines for the Management of Bacterial Meningitis (IDSA). Clin Infect Dis. 2004.
  3. US FDA Drug Safety Communication — Ceftriaxone and calcium-containing products in neonates.

Related calculators

⚠️ For qualified healthcare professionals. Weight-based estimate only — verify against local antibiotic guidelines, the product insert, and the patient's renal/hepatic function and allergy history before prescribing.

← Back to Antibiotics